252 related articles for article (PubMed ID: 33138842)
1. DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.
Alberge JB; Magrangeas F; Wagner M; Denié S; Guérin-Charbonnel C; Campion L; Attal M; Avet-Loiseau H; Carell T; Moreau P; Minvielle S; Sérandour AA
Clin Epigenetics; 2020 Nov; 12(1):163. PubMed ID: 33138842
[TBL] [Abstract][Full Text] [Related]
2. Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.
Alvarez-Benayas J; Trasanidis N; Katsarou A; Ponnusamy K; Chaidos A; May PC; Xiao X; Bua M; Atta M; Roberts IAG; Auner HW; Hatjiharissi E; Papaioannou M; Caputo VS; Sudbery IM; Karadimitris A
Nat Commun; 2021 Sep; 12(1):5450. PubMed ID: 34521827
[TBL] [Abstract][Full Text] [Related]
3. Age-related epigenome-wide DNA methylation and hydroxymethylation in longitudinal mouse blood.
Kochmanski J; Marchlewicz EH; Cavalcante RG; Sartor MA; Dolinoy DC
Epigenetics; 2018; 13(7):779-792. PubMed ID: 30079798
[TBL] [Abstract][Full Text] [Related]
4. Environmental Epigenetics and Genome Flexibility: Focus on 5-Hydroxymethylcytosine.
Efimova OA; Koltsova AS; Krapivin MI; Tikhonov AV; Pendina AA
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370155
[TBL] [Abstract][Full Text] [Related]
5. The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma.
Choudhury SR; Ashby C; Tytarenko R; Bauer M; Wang Y; Deshpande S; Den J; Schinke C; Zangari M; Thanendrarajan S; Davies FE; van Rhee F; Morgan GJ; Walker BA
J Hematol Oncol; 2020 Aug; 13(1):108. PubMed ID: 32762714
[TBL] [Abstract][Full Text] [Related]
6. The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation.
Chatonnet F; Pignarre A; Sérandour AA; Caron G; Avner S; Robert N; Kassambara A; Laurent A; Bizot M; Agirre X; Prosper F; Martin-Subero JI; Moreaux J; Fest T; Salbert G
Haematologica; 2020 Mar; 105(3):774-783. PubMed ID: 31221779
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide characterization of cytosine-specific 5-hydroxymethylation in normal breast tissue.
Wilkins OM; Johnson KC; Houseman EA; King JE; Marsit CJ; Christensen BC
Epigenetics; 2020 Apr; 15(4):398-418. PubMed ID: 31842685
[TBL] [Abstract][Full Text] [Related]
8. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
[TBL] [Abstract][Full Text] [Related]
9. Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma.
Fernandez AF; Bayón GF; Sierra MI; Urdinguio RG; Toraño EG; García MG; Carella A; López V; Santamarina P; Pérez RF; Belmonte T; Tejedor JR; Cobo I; Menendez P; Mangas C; Ferrero C; Rodrigo L; Astudillo A; Ortea I; Cueto Díaz S; Rodríguez-Gonzalez P; García Alonso JI; Mollejo M; Meléndez B; Domínguez G; Bonilla F; Fraga MF
Hum Mol Genet; 2018 Sep; 27(17):3046-3059. PubMed ID: 29878202
[TBL] [Abstract][Full Text] [Related]
10. Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer.
Hu H; Shu M; He L; Yu X; Liu X; Lu Y; Chen Y; Miao X; Chen X
Br J Cancer; 2017 Feb; 116(5):658-668. PubMed ID: 28141796
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer.
Storebjerg TM; Strand SH; Høyer S; Lynnerup AS; Borre M; Ørntoft TF; Sørensen KD
Clin Epigenetics; 2018 Aug; 10(1):105. PubMed ID: 30086793
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
13. Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment?
Xu T; Gao H
Hum Genomics; 2020 May; 14(1):15. PubMed ID: 32375881
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA.
Skvortsova K; Zotenko E; Luu PL; Gould CM; Nair SS; Clark SJ; Stirzaker C
Epigenetics Chromatin; 2017; 10():16. PubMed ID: 28428825
[TBL] [Abstract][Full Text] [Related]
15. Distal regulatory elements identified by methylation and hydroxymethylation haplotype blocks from mouse brain.
Ma Q; Xu Z; Lu H; Xu Z; Zhou Y; Yuan B; Ci W
Epigenetics Chromatin; 2018 Dec; 11(1):75. PubMed ID: 30594220
[TBL] [Abstract][Full Text] [Related]
16. Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.
Popovic R; Martinez-Garcia E; Giannopoulou EG; Zhang Q; Zhang Q; Ezponda T; Shah MY; Zheng Y; Will CM; Small EC; Hua Y; Bulic M; Jiang Y; Carrara M; Calogero RA; Kath WL; Kelleher NL; Wang JP; Elemento O; Licht JD
PLoS Genet; 2014 Sep; 10(9):e1004566. PubMed ID: 25188243
[TBL] [Abstract][Full Text] [Related]
17. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.
Martinez-Garcia E; Popovic R; Min DJ; Sweet SM; Thomas PM; Zamdborg L; Heffner A; Will C; Lamy L; Staudt LM; Levens DL; Kelleher NL; Licht JD
Blood; 2011 Jan; 117(1):211-20. PubMed ID: 20974671
[TBL] [Abstract][Full Text] [Related]
18. Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma.
Ahsan S; Raabe EH; Haffner MC; Vaghasia A; Warren KE; Quezado M; Ballester LY; Nazarian J; Eberhart CG; Rodriguez FJ
Acta Neuropathol Commun; 2014 Jun; 2():59. PubMed ID: 24894482
[TBL] [Abstract][Full Text] [Related]
19. Cytosine modifications modulate the chromatin architecture of transcriptional enhancers.
Mahé EA; Madigou T; Sérandour AA; Bizot M; Avner S; Chalmel F; Palierne G; Métivier R; Salbert G
Genome Res; 2017 Jun; 27(6):947-958. PubMed ID: 28396520
[TBL] [Abstract][Full Text] [Related]
20. Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.
Misiewicz-Krzeminska I; Sarasquete ME; Vicente-Dueñas C; Krzeminski P; Wiktorska K; Corchete LA; Quwaider D; Rojas EA; Corral R; Martín AA; Escalante F; Bárez A; García JL; Sánchez-García I; García-Sanz R; San Miguel JF; Gutiérrez NC
Clin Cancer Res; 2016 Jan; 22(1):207-17. PubMed ID: 26341922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
